AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Oncopeptides

Major Shareholding Notification Jun 5, 2024

3091_iss_2024-06-05_1437e452-0f3a-423a-b7bb-0ca34780fcee.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Oncopeptides AB

Holder

Nordnet AB (publ)

Instrument

Instrument Aktie SE0009414576
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Sell
Date 04/06/2024
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 10,510,123
Directly held voting rights 0
Indirectly held voting rights 10,510,123
Percentage
Directly held shares 4.88419 %
Directly held voting rights 0 %
Indirectly held voting rights 4.97069 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 4.97069 % 10,510,123
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 4.97069 % 10,510,123

Chain of controlling companies

Voting rights % Voting rights Company
10,179,078 4.81412 Nordnet Pensionsförsäkring AB
331,045 0.15656 Nordnet Livsforsikring AS
Group
total
holdings
Voting rights 10,510,123
Percentage of voting rights 4.97069

Published

05/06/2024 12:52

Contact Name David Ohlsson Phone 0709497952 Email [email protected]

*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.